Integrating Precision Medicine into the Contemporary Management of Gynecologic Cancers.

The treatment of patients with advanced gynecologic malignancies remains challenging. The adoption of targeted therapeutics for the treatment of gynecologic cancers has been gradual, but we have started to see the rapid employment of novel targeted agents into clinical trial development, leading to new treatment approvals.

⚡ This is an original paraphrased summary — not copied from the abstract. Full paper available at the source link below.

• 1 Advancements in genomics have led to recognition and development of individualized therapeutic targets.
• 2 This article reviews the current trends in precision medicine for treatment of gynecologic cancers.
• 3 With the identification of the molecular aberrations inherent to gynecologic malignancies, we have discovered targetable mutations.

Understanding this could lead to better treatments, improved diagnostics, or a deeper grasp of how the human body works — benefiting patient care globally.

This summary is based on publicly available metadata and abstract. For the full research paper, visit the original source: